Urolithiasis (2014) 42:445–453 DOI 10.1007/s00240-014-0687-7
ORIGINAL PAPER
Hemostatic agents used for nephrostomy tract closure after tubeless PCNL: a systematic review and meta‑analysis Cui Yu · Zhou Xu · Wang Long · Liu Longfei · Zeng Feng · Qi Lin · Zu Xiongbing · Chen Hequn
Received: 8 June 2014 / Accepted: 4 July 2014 / Published online: 27 July 2014 © Springer-Verlag Berlin Heidelberg 2014
Abstract To evaluate the role of hemostatic agents used for nephrostomy tract closure after tubeless percutaneous nephrolithotomy (PCNL). A systematic review of Pubmed, Embase and Cochrane was performed. All studies that compared hemostatic agents with common methods (silk stitch or pressure dressing) were included. The analyzed outcomes were hospital stay, operative time, blood loss, transfusion rate, fever rate, and complication rate. A total of eight articles including six RCTs met our criteria. Hemostatic agents showed short hospital stay (MD −4.54, 95 % CI −6.78 to −2.36, p
ORIGINAL PAPER
Hemostatic agents used for nephrostomy tract closure after tubeless PCNL: a systematic review and meta‑analysis Cui Yu · Zhou Xu · Wang Long · Liu Longfei · Zeng Feng · Qi Lin · Zu Xiongbing · Chen Hequn
Received: 8 June 2014 / Accepted: 4 July 2014 / Published online: 27 July 2014 © Springer-Verlag Berlin Heidelberg 2014
Abstract To evaluate the role of hemostatic agents used for nephrostomy tract closure after tubeless percutaneous nephrolithotomy (PCNL). A systematic review of Pubmed, Embase and Cochrane was performed. All studies that compared hemostatic agents with common methods (silk stitch or pressure dressing) were included. The analyzed outcomes were hospital stay, operative time, blood loss, transfusion rate, fever rate, and complication rate. A total of eight articles including six RCTs met our criteria. Hemostatic agents showed short hospital stay (MD −4.54, 95 % CI −6.78 to −2.36, p
